Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Cardiac Surgery with Pulmonary Hypertension
NCT04599816Completed
- Sponsor
- Aretaieion University Hospital
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levosimendan in pulmonary hypertension (PH) and right-sided heart failure (3 arms), sponsored by Aretaieion University Hospital. Primary endpoint: Mean Pulmonary Arterial Pressure. Started Oct 2020; status: completed.
02
Drugs
levosimendan
03
Conditions
pulmonary hypertension (PH)right-sided heart failure
Beyond the preview
Go deeper on NCT04599816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04599816.